TORONTO, Ontario and CAMBRIDGE, Massachusetts, April 07, 2022 (World NEWSWIRE) — ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or the “Corporation”), is happy to announce it has mailed the See of Observe-and-Access (the “N&A Notice”) to shareholders of file of the Corporation as of April 01, 2022, in link with the Annual Typical and Special Meeting of the Shareholders (the “Meeting”) of the Corporation to be held Thursday, Could 12, 2022, at 9:00 a.m. (Pacific Time). In compliance with securities regulations, the Corporation has also posted the N&A Discover with each other with the put together Observe of Once-a-year and Unique Meeting of the Shareholders and Management Proxy Round, and the form of Proxy similar to the Meeting less than the Corporation’s profile at www.sedar.com and on the Corporation’s web page at https://www.promisneurosciences.com/.
In consideration of the recent coronavirus COVID-19 pandemic (“COVID-19”), the Company will keep the Meeting on the net by way of stay virtual webcast at https://meetnow.global/MZUVNJS.
YOUR VOTE IS Essential – You should VOTE These days
At the Meeting, Shareholders will be questioned to contemplate and vote on the pursuing:
ELECTION OF Directors: To elect eight administrators of the Corporation for the ensuing calendar year. See Election of Directors in the Round.
APPOINTMENT OF AUDITOR: To appoint the auditor of the Corporation for the ensuing yr and to authorize the administrators to fix the auditor’s remuneration. See Appointment of Auditor in the Round.
Amendment OF BY-Legislation: To approve an normal resolution to ratify, validate and approve modification by the Board of Directors of the By-Rules of the Company to eliminate the Board’s alternative to appoint alternate administrators and to change the definition of quorum for a conference of the Shareholders to maximize quorum from 1-twentieth, staying 5 (5%) p.c, to 30-a few and one particular-3rd (33 1/3%) percent of the issued Prevalent Shares from time to time. The goal of the modification is to deliver the Corporation’s governing constitution in line with the necessities of various main North American exchanges. See Particulars of Issues to be Acted upon – Amendment of By-Guidelines in the Management Proxy Circular geared up for the Conference and submitted below the Corporation’s profile at www.sedar.com and on the Corporation’s site at https://www.promisneurosciences.com/.
The Board of Administrators of ProMIS endorses that Shareholders
vote in favor of all proposed things.
ProMIS encourages shareholders to read through the conference substance, which have been submitted underneath the profile of ProMIS at www.sedar.com and on the Corporation’s web site at https://www.promisneurosciences.com/.
Shareholder Details and Concerns
If you have issues or have to have support with voting, be sure to speak to Laurel Hill Advisory Group, the Corporation’s proxy solicitation and facts agent:
Laurel Hill Advisory Group
North American Toll-Cost-free Quantity: 1-877-452-7184
Phone calls Outside the house North The usa: 416-304-0211
E-mail: [email protected]
About ProMIS Neurosciences Inc.
ProMIS Neurosciences Inc. is a improvement phase biotechnology company centered on discovering and acquiring antibody therapeutics selectively focusing on toxic oligomers implicated in the development and development of neurodegenerative disorders, in specific Alzheimer’s ailment (Advert), amyotrophic lateral sclerosis (ALS) and Many program atrophy (MSA). The Corporation’s proprietary focus on discovery engine is primarily based on the use of two complementary tactics. The Company applies its thermodynamic, computational discovery platform – ProMIS™ and Collective Coordinates – to predict novel targets identified as Disorder Distinct Epitopes on the molecular floor of misfolded proteins. Employing this unique technique, the Company is establishing novel antibody therapeutics for Ad, ALS and MSA. ProMIS is headquartered in Toronto, Ontario, Canada with offices in Cambridge, Massachusetts, U.S.A. ProMIS is shown on the Toronto Stock Exchange (“TSX”) less than image PMN, and on the OTCQB Venture Marketplace beneath image ARFXF.
For Investor Relations please get in touch with:
Alpine Equity Advisors
Nicholas Rigopulos, President
Tel. 617 901-0785
The TSX has not reviewed and does not acknowledge accountability for the adequacy or accuracy of this release. Particular data in this news launch constitutes forward-searching statements and forward-looking details (collectively, ”ahead-seeking facts”) in the which means of relevant securities guidelines. In some instances, but not necessarily in all conditions, forward-hunting information can be identified by the use of ahead-searching terminology such as “plans”, “targets”, “expects” or “does not assume”, “is expected”, “an possibility exists”, ”is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or versions of this kind of phrases and phrases or point out that specific actions, gatherings or success “may well”, “could”, “would”, “could possibly”, “will” or “will be taken”, “occur” or “be achieved”. In addition, any statements that refer to expectations, projections or other characterizations of long run events or circumstances have ahead-on the lookout data. Specifically, this news release consists of ahead-looking facts relating to potential management and Board composition of the Company and the probable benefits of targeting misfolded proteins. Statements that contains ahead-wanting information are not historic points but in its place symbolize management’s existing expectations, estimates and projections regarding the long term of our company, long run ideas, methods, projections, expected situations and developments, the economic climate and other future ailments. Ahead-hunting facts is necessarily primarily based on a amount of views, assumptions and estimates that, although regarded as fair by the Corporation as of the date of this information release, are topic to known and unidentified dangers, uncertainties, assumptions and other elements that may well result in the precise outcomes, amount of activity, performance or achievements to be materially distinct from these expressed or implied by these forward-wanting information and facts. Critical things that could induce true effects and money condition to differ materially from those people indicated in the ahead-wanting info consist of, amongst some others, the aspects reviewed through the “Threat Components” portion of the Company‘s most just lately filed yearly details form accessible on www.SEDAR.com. On top of that, notwithstanding whether or not the amendment to modify the quorum need is approved by shareholders or or else, there is no assurance that the organization will meet up with the quantitative or qualitative prerequisites to checklist on a significant North American stock trade. Except as needed by relevant securities rules, the Company undertakes no obligation to publicly update any forward-wanting information and facts, no matter whether created or oral, that might be made from time to time, whether or not as a final result of new data, foreseeable future developments or if not.